{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:38:25Z","timestamp":1776440305245,"version":"3.51.2"},"reference-count":79,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-75-10097"],"award-info":[{"award-number":["19-75-10097"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Viruses can be spread from one person to another; therefore, they may cause disorders in many people, sometimes leading to epidemics and even pandemics. New, previously unstudied viruses and some specific mutant or recombinant variants of known viruses constantly appear. An example is a variant of coronaviruses (CoV) causing severe acute respiratory syndrome (SARS), named SARS-CoV-2. Some antiviral drugs, such as remdesivir as well as antiretroviral drugs including darunavir, lopinavir, and ritonavir are suggested to be effective in treating disorders caused by SARS-CoV-2. There are data on the utilization of antiretroviral drugs against SARS-CoV-2. Since there are many studies aimed at the identification of the molecular mechanisms of human immunodeficiency virus type 1 (HIV-1) infection and the development of novel therapeutic approaches against HIV-1, we used HIV-1 for our case study to identify possible molecular pathways shared by SARS-CoV-2 and HIV-1. We applied a text and data mining workflow and identified a list of 46 targets, which can be essential for the development of infections caused by SARS-CoV-2 and HIV-1. We show that SARS-CoV-2 and HIV-1 share some molecular pathways involved in inflammation, immune response, cell cycle regulation.<\/jats:p>","DOI":"10.3390\/molecules25122944","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T14:27:29Z","timestamp":1593527249000},"page":"2944","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3723-7832","authenticated-orcid":false,"given":"Olga","family":"Tarasova","sequence":"first","affiliation":[{"name":"Department for Bioinformatics, Institute of Biomedical Chemistry, 107076 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3177-6237","authenticated-orcid":false,"given":"Sergey","family":"Ivanov","sequence":"additional","affiliation":[{"name":"Department for Bioinformatics, Institute of Biomedical Chemistry, 107076 Moscow, Russia"},{"name":"Department of Bioinformatics of Pirogov Russian National Research Medical University, 107076 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-8478","authenticated-orcid":false,"given":"Dmitry A.","family":"Filimonov","sequence":"additional","affiliation":[{"name":"Department for Bioinformatics, Institute of Biomedical Chemistry, 107076 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7937-2621","authenticated-orcid":false,"given":"Vladimir","family":"Poroikov","sequence":"additional","affiliation":[{"name":"Department for Bioinformatics, Institute of Biomedical Chemistry, 107076 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"a006841","DOI":"10.1101\/cshperspect.a006841","article-title":"Origins of HIV and the AIDS pandemic","volume":"1","author":"Sharp","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.4081\/jphr.2020.1786","article-title":"COVID-19 pandemic: Emerging perspectives and future trends","volume":"9","author":"Tabish","year":"2020","journal-title":"J. Public Health Res."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Gordon, D.E., Jang, G.M., Bouhaddou, M., Xu, J., Obernier, K., White, K.M., O\u2019Meara, M.J., Rezelj, V.V., Guo, J.Z., and Swaney, D.L. (2020). A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature.","DOI":"10.1038\/s41586-020-2286-9"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1126\/science.abb9332","article-title":"Rapid repurposing of drugs for COVID-19","volume":"368","author":"Guy","year":"2020","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13046-020-01590-2","article-title":"Drug repurposing against COVID-19: Focus on anticancer agents","volume":"39","author":"Ciliberto","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sayad, B., Sobhani, M., and Khodarahmi, R. (2020). Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered\/Approved Clinical Trial?. Arch. Med. Res., S0188440920305518.","DOI":"10.1016\/j.arcmed.2020.04.018"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Alsuliman, T., Alasadi, L., Alkharat, B., Srour, M., and Alrstom, A. (2020). A review of potential treatments to date in COVID-19 patients according to the stage of the disease. Curr Res. Transl. Med.","DOI":"10.1016\/j.retram.2020.05.004"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Pawar, A.Y. (2020). Combating devastating COVID-19 by drug repurposing. Int. J. Antimicrob. Agents, 105984.","DOI":"10.1016\/j.ijantimicag.2020.105984"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Khan, R.J., Jha, R.K., Amera, G.M., Jain, M., Singh, E., Pathak, A., Singh, R.P., Muthukumaran, J., and Singh, A.K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2\u2032-O-ribose methyltransferase. J. Biomol. Struct. Dyn., 1\u201314.","DOI":"10.26434\/chemrxiv.11888730"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Parang, K., El-Sayed, N.S., Kazeminy, A.J., and Tiwari, R.K. (2020). Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E). Molecules, 25.","DOI":"10.3390\/molecules25102343"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e25489","DOI":"10.1002\/jia2.25489","article-title":"Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: Initial assessment","volume":"23","author":"Ford","year":"2020","journal-title":"J. Int. AIDS Soc."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kim, J.-W., Kim, E.J., Kwon, H.H., Jung, C.Y., Kim, K.C., Choe, J.-Y., and Hong, H.-L. (2020). Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019. Korean J. Intern. Med.","DOI":"10.3904\/kjim.2020.224"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Panagopoulos, P., Petrakis, V., Panopoulou, M., Trypsianis, G., Penlioglou, T., Pnevmatikos, I., and Papazoglou, D. (2020). Lopinavir\/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection. J. Chemother., 1\u20135.","DOI":"10.1080\/1120009X.2020.1775424"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Lima, W.G., Brito, J.C.M., Overhage, J., and Nizer, W.S.d.C. (2020). The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): A systematic review. Arch. Virol.","DOI":"10.1007\/s00705-020-04693-5"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., and Lu, L. (2020). SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell. Mol. Immunol.","DOI":"10.1038\/s41423-020-0424-9"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","article-title":"Lymphopenia predicts disease severity of COVID-19: A descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1021\/acs.jcim.7b00589","article-title":"Chemotext: A Publicly Available Web Server for Mining Drug\u2013Target\u2013Disease Relationships in PubMed","volume":"58","author":"Capuzzi","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1021\/acs.jcim.9b00164","article-title":"Data Mining Approach for Extraction of Useful Information About Biologically Active Compounds from Publications","volume":"59","author":"Tarasova","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"ref_19","unstructured":"Available online: https:\/\/talk.ictvonline.org\/."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/22221751.2020.1727299","article-title":"HIV-1 did not contribute to the 2019-nCoV genome","volume":"9","author":"Xiao","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chen, K.-C., Wang, T.-Y., and Chan, C. (2012). Associations between HIV and human pathways revealed by protein-protein interactions and correlated gene expression profiles. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034240"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2174\/1568026615666150901115106","article-title":"Targeting Virus-host Interactions of HIV Replication","volume":"16","author":"Weydert","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_23","first-page":"31","article-title":"Virus-Host Gene Interactions Define HIV-1 Disease Progression","volume":"407","author":"Monaco","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response","volume":"14","author":"Astuti","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/jgv.0.000728","article-title":"Combination antiretroviral therapy and cell-cell spread of wild-type and drug-resistant human immunodeficiency virus-1","volume":"98","author":"Titanji","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.1663","article-title":"Human hematopoietic stem\/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo","volume":"28","author":"Holt","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","article-title":"Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9","volume":"15","author":"Mandal","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3389\/fmicb.2018.02940","article-title":"Gene Editing of HIV-1 Co-receptors to Prevent and\/or Cure Virus Infection","volume":"9","author":"Allen","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.chom.2020.04.021","article-title":"The Challenges of Vaccine Development against a New Virus during a Pandemic","volume":"27","author":"Diamond","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/s41467-019-10366-y","article-title":"Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice","volume":"10","author":"Dash","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"104859","DOI":"10.1016\/j.phrs.2020.104859","article-title":"Candidate drugs against SARS-CoV-2 and COVID-19","volume":"157","author":"McKee","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Perricone, C., Triggianese, P., Bartoloni, E., Cafaro, G., Bonifacio, A.F., Bursi, R., Perricone, R., and Gerli, R. (2020). The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. J. Autoimmun., 102468.","DOI":"10.1016\/j.jaut.2020.102468"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: A storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-4933-11-4","article-title":"Severe acute respiratory syndrome-coronavirus infection in aged nonhuman primates is associated with modulated pulmonary and systemic immune responses","volume":"11","author":"Clay","year":"2014","journal-title":"Immun. Ageing"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zhou, G., Chen, S., and Chen, Z. (2020). Advances in COVID-19: The virus, the pathogenesis, and evidence-based control and therapeutic strategies. Front. Med.","DOI":"10.1007\/s11684-020-0773-x"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"(2017). The UniProt Consortium UniProt: The universal protein knowledgebase. Nucleic Acids Res., 45, D158\u2013D169.","DOI":"10.1093\/nar\/gkw1099"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: New perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_38","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Ronzano","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_39","unstructured":"(2020, April 04). Clarivate Analytics Integrity Home Page. Available online: https:\/\/integrity.clarivate.com\/integrity\/xmlxsl\/."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.4049\/jimmunol.1303196","article-title":"SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS\/TRAF3\/TRAF6 signalosome","volume":"193","author":"Shi","year":"2014","journal-title":"J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"41481","DOI":"10.1074\/jbc.M112.361782","article-title":"HIV-1 Nef impairs heterotrimeric G-protein signaling by targeting G\u03b1(i2) for degradation through ubiquitination","volume":"287","author":"Chandrasekaran","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s13238-014-0104-6","article-title":"Coronavirus membrane-associated papain-like proteases induce autophagy through interacting with Beclin1 to negatively regulate antiviral innate immunity","volume":"5","author":"Chen","year":"2014","journal-title":"Protein Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11481-018-9788-3","article-title":"Critical Role of Beclin1 in HIV Tat and Morphine-Induced Inflammation and Calcium Release in Glial Cells from Autophagy Deficient Mouse","volume":"13","author":"Lapierre","year":"2018","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1038\/s41467-019-13659-4","article-title":"SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection","volume":"10","author":"Gassen","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.15698\/mic2020.05.715","article-title":"Digesting the crisis: Autophagy and coronaviruses","volume":"7","author":"Bauer","year":"2020","journal-title":"Microb. Cell"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Pooladanda, V., Thatikonda, S., and Godugu, C. (2020). The current understanding and potential therapeutic options to combat COVID-19. Life Sci., 117765.","DOI":"10.1016\/j.lfs.2020.117765"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"104941","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104941","article-title":"Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights","volume":"29","author":"Divani","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Yoshii, H., Kamiyama, H., Goto, K., Oishi, K., Katunuma, N., Tanaka, Y., Hayashi, H., Matsuyama, T., Sato, H., and Yamamoto, N. (2011). CD4-independent human immunodeficiency virus infection involves participation of endocytosis and cathepsin B. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019352"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"107587","DOI":"10.1016\/j.pharmthera.2020.107587","article-title":"Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients","volume":"213","author":"Liu","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Hopkins, J., Yadavalli, T., Agelidis, A.M., and Shukla, D. (2018). Host Enzymes Heparanase and Cathepsin L Promote Herpes Simplex Virus 2 Release from Cells. J. Virol., 92.","DOI":"10.1128\/JVI.01179-18"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1570162X12666140526120249","article-title":"Macrophage derived cystatin B\/cathepsin B in HIV replication and neuropathogenesis","volume":"12","author":"Rivera","year":"2014","journal-title":"Curr. HIV Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"8006","DOI":"10.1038\/s41598-019-44463-1","article-title":"HIV Infection Induces Extracellular Cathepsin B Uptake and Damage to Neurons","volume":"9","author":"Plaud","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/QAD.0b013e32835b3e47","article-title":"Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders","volume":"27","author":"Gerena","year":"2013","journal-title":"AIDS"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Hu, Y., Li, W., Gao, T., Cui, Y., Jin, Y., Li, P., Ma, Q., Liu, X., and Cao, C. (2017). The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination. J. Virol., 91.","DOI":"10.1128\/JVI.02143-16"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e00088-17","DOI":"10.1128\/JVI.00088-17","article-title":"TRIM25 Is Required for the Antiviral Activity of Zinc Finger Antiviral Protein","volume":"91","author":"Zheng","year":"2017","journal-title":"J. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbrc.2020.04.136","article-title":"Biochemical characterization of SARS-CoV-2 nucleocapsid protein","volume":"527","author":"Zeng","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Soy, M., Keser, G., Atag\u00fcnd\u00fcz, P., Tabak, F., Atag\u00fcnd\u00fcz, I., and Kayhan, S. (2020). Cytokine storm in COVID-19: Pathogenesis and overview of anti-inflammatory agents used in treatment. Clin. Rheumatol.","DOI":"10.1007\/s10067-020-05190-5"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.bbagen.2014.03.007","article-title":"Matrix metalloproteinases in inflammation","volume":"1840","author":"Nissinen","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Muema, D.M., Akilimali, N.A., Ndumnego, O.C., Rasehlo, S.S., Durgiah, R., Ojwach, D.B.A., Ismail, N., Dong, M., Moodley, A., and Dong, K.L. (2020). Association between the cytokine storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection. BMC Med., 18.","DOI":"10.1186\/s12916-020-01529-6"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Gralinski, L.E., Sheahan, T.P., Morrison, T.E., Menachery, V.D., Jensen, K., Leist, S.R., Whitmore, A., Heise, M.T., and Baric, R.S. (2018). Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. mBio, 9.","DOI":"10.1128\/mBio.01753-18"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12974-017-0794-9","article-title":"HIV induces expression of complement component C3 in astrocytes by NF-\u03baB-dependent activation of interleukin-6 synthesis","volume":"14","author":"Nitkiewicz","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/infdis\/jiv074","article-title":"HIV Coinfection Enhances Complement Activation During Sepsis","volume":"212","author":"Huson","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"108450","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/cmi.2010.8","article-title":"The good and evil of complement activation in HIV-1 infection","volume":"7","author":"Yu","year":"2010","journal-title":"Cell Mol. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4049\/jimmunol.1102179","article-title":"A common polymorphism in TLR3 confers natural resistance to HIV-1 infection","volume":"188","author":"Sironi","year":"2012","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.meegid.2013.08.008","article-title":"Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users","volume":"20","author":"Huik","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1172\/JCI99005","article-title":"TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs","volume":"128","author":"Cheng","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Lim, S.-Y., Osuna, C.E., Hraber, P.T., Hesselgesser, J., Gerold, J.M., Barnes, T.L., Sanisetty, S., Seaman, M.S., Lewis, M.G., and Geleziunas, R. (2018). TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy. Sci. Transl. Med., 10.","DOI":"10.1126\/scitranslmed.aao4521"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3389\/fimmu.2020.01229","article-title":"Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?","volume":"11","author":"Sallenave","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"244","DOI":"10.21037\/atm.2020.01.84","article-title":"Killer immunoglobulin-like receptors\/human leukocyte antigen class-I, a crucial immune pathway in cancer","volume":"8","author":"Xu","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.omtn.2020.04.002","article-title":"The Interplay among miRNAs, Major Cytokines, and Cancer-Related Inflammation","volume":"20","author":"Chakraborty","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.autrev.2017.07.022","article-title":"Cancer and autoimmune diseases","volume":"16","author":"Giat","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Yin, Q., Wyatt, C.J., Han, T., Smalley, K.S.M., and Wan, L. (2020). ITCH as a potential therapeutic target in human cancers. Semin. Cancer Biol.","DOI":"10.1016\/j.semcancer.2020.03.003"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Liu, A.Y. (2020). Infectious Implications of Interleukin-1, Interleukin-6, and T Helper Type 2 Inhibition. Infect. Dis. Clin. N. Am.","DOI":"10.1016\/j.idc.2020.02.003"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/bioinformatics\/btg1023","article-title":"GENIA corpus--semantically annotated corpus for bio-textmining","volume":"19","author":"Kim","year":"2003","journal-title":"Bioinformatics"},{"key":"ref_78","unstructured":"Available online: https:\/\/www.UniProt.org\/help\/api_queries."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/bib\/bbr042","article-title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium","volume":"12","author":"Gaudet","year":"2011","journal-title":"Brief. Bioinform."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/12\/2944\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:43:13Z","timestamp":1760175793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/12\/2944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":79,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["molecules25122944"],"URL":"https:\/\/doi.org\/10.3390\/molecules25122944","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]}}}